The Keio University-backed digital medicine developer has secured $19.3m from a consortium including several Japanese corporations.

Japan-based medical treatment app provider CureApp has raised ¥2.1bn ($19.3m) from investors including corporates Dai-ichi Life, Itochu, Koshidaka and Toyoshima & Co, taking its total funding to roughly $58.8m. Financial services firms Shoko Chukin Bank and Sumitomo Mitsui Banking Corporation (SMBC) also took part in the round, as did Healthcare Innovation, Saisei Ventures and Sumitomo…

The rest of this content is only accessible to University Venturing: News, Data and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.